Literature DB >> 273269

Radiosensitization by misonidazole (Ro 07-0582). The importance of timing and tumor concentration of sensitizer.

N J McNally, J Denekamp, P Sheldon, I R Flockhart, F A Stewart.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 273269

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


× No keyword cloud information.
  18 in total

1.  Dose-dependence and related studies on the pharmacokinetics of misonidazole and desmethylmisonidazole in mice.

Authors:  P Workman
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

2.  Radiosensitisers.

Authors: 
Journal:  Br Med J       Date:  1980-10-25

3.  The pharmacokinetics of a new radiosensitiser, Ro 03-8799 in humans.

Authors:  J G Allen; S Dische; I Lenox-Smith; S L Malcolm; M I Saunders
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

4.  Distribution and tumor penetration properties of a radiosensitizer 2-[14C] misonidazole (Ro 07-0582), in mice and rats as studied by whole-body autoradiography.

Authors:  G Akel; P Benard; P Canal; G Soula
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

5.  In vivo-in vitro tumour cell lines: characteristics and limitations as models for human cancer.

Authors:  S Rockwell
Journal:  Br J Cancer Suppl       Date:  1980-04

6.  Bioreductive drugs and the selective induction of tumour hypoxia.

Authors:  J C Bremner; I J Stratford; J Bowler; G E Adams
Journal:  Br J Cancer       Date:  1990-05       Impact factor: 7.640

7.  Radiation sensitization and chemopotentiation: RSU 1069, a compound more efficient than misonidazole in vitro and in vivo.

Authors:  G E Adams; I Ahmed; P W Sheldon; I J Stratford
Journal:  Br J Cancer       Date:  1984-05       Impact factor: 7.640

8.  Enhancement of the effect of cytotoxic drugs by radiosensitizers.

Authors:  W M Martin; N J McNally; J De Ronde
Journal:  Br J Cancer       Date:  1981-06       Impact factor: 7.640

9.  Is tumour radiosensitization by misonidazole a general phenomenon?

Authors:  J Denekamp; D G Hirst; F A Stewart; N H Terry
Journal:  Br J Cancer       Date:  1980-01       Impact factor: 7.640

10.  Pharmacokinetic considerations in testing hypoxic cell radiosensitizers in mouse tumours.

Authors:  J M Brown; N Y Yu; P Workman
Journal:  Br J Cancer       Date:  1979-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.